177 related articles for article (PubMed ID: 27447978)
1. Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.
Martinez-Garcia E; Lesur A; Devis L; Campos A; Cabrera S; van Oostrum J; Matias-Guiu X; Gil-Moreno A; Reventos J; Colas E; Domon B
Oncotarget; 2016 Aug; 7(33):53102-53115. PubMed ID: 27447978
[TBL] [Abstract][Full Text] [Related]
2. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
[No Abstract] [Full Text] [Related]
3. Identification and validation of serum metabolite biomarkers for endometrial cancer diagnosis.
Liu W; Ma J; Zhang J; Cao J; Hu X; Huang Y; Wang R; Wu J; Di W; Qian K; Yin X
EMBO Mol Med; 2024 Apr; 16(4):988-1003. PubMed ID: 38355748
[TBL] [Abstract][Full Text] [Related]
4. A proteomic approach for the identification of biomarkers in endometrial cancer uterine aspirate.
Ura B; Monasta L; Arrigoni G; Franchin C; Radillo O; Peterlunger I; Ricci G; Scrimin F
Oncotarget; 2017 Dec; 8(65):109536-109545. PubMed ID: 29312627
[TBL] [Abstract][Full Text] [Related]
5. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers of endometrial carcinoma detected in uterine aspirates.
Colas E; Perez C; Cabrera S; Pedrola N; Monge M; Castellvi J; Eyzaguirre F; Gregorio J; Ruiz A; Llaurado M; Rigau M; Garcia M; Ertekin T; Montes M; Lopez-Lopez R; Carreras R; Xercavins J; Ortega A; Maes T; Rosell E; Doll A; Abal M; Reventos J; Gil-Moreno A
Int J Cancer; 2011 Nov; 129(10):2435-44. PubMed ID: 21207424
[TBL] [Abstract][Full Text] [Related]
7. Advances in endometrial cancer protein biomarkers for use in the clinic.
Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
[TBL] [Abstract][Full Text] [Related]
8. RAB8A a new biomarker for endometrial cancer?
Bie Y; Zhang Z
World J Surg Oncol; 2014 Dec; 12():371. PubMed ID: 25477298
[TBL] [Abstract][Full Text] [Related]
9. Qualification and Verification of Protein Biomarker Candidates.
Zhao Y; Brasier AR
Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
[TBL] [Abstract][Full Text] [Related]
10. [Applications of DNA chip technology and protein mass spectrometry in the studies of reproduction and endocrinology].
Han CS
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):361-3. PubMed ID: 16831353
[No Abstract] [Full Text] [Related]
11. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format.
Dubé V; Grigull J; DeSouza LV; Ghanny S; Colgan TJ; Romaschin AD; Siu KW
J Proteome Res; 2007 Jul; 6(7):2648-55. PubMed ID: 17552551
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of endometrial cancer from uterine aspirates.
Perez-Sanchez C; Colas E; Cabrera S; Falcon O; Sanchez-del-Río A; García E; Fernández-de-Castillo L; Muruzabal JC; Alvarez E; Fiol G; González C; Torrejón R; Moral E; Campos M; Repollés M; Carreras R; Jiménez-López J; Xercavins J; Aibar E; Perdones-Montero A; Lalanne E; Palicio M; Maes T; Rosell-Vives E; Nieto C; Ortega A; Pedrola N; Llauradó M; Rigau M; Doll A; Abal M; Ponce J; Gil-Moreno A; Reventós J
Int J Cancer; 2013 Nov; 133(10):2383-91. PubMed ID: 23649867
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
14. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
[TBL] [Abstract][Full Text] [Related]
15. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
16. Gel-Based Proteomic Identification of Suprabasin as a Potential New Candidate Biomarker in Endometrial Cancer.
Celsi F; Monasta L; Arrigoni G; Battisti I; Licastro D; Aloisio M; Di Lorenzo G; Romano F; Ricci G; Ura B
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216190
[TBL] [Abstract][Full Text] [Related]
17. Discovery of biomarkers of endometrial receptivity through a minimally invasive approach: a validation study with implications for assisted reproduction.
Chan C; Virtanen C; Winegarden NA; Colgan TJ; Brown TJ; Greenblatt EM
Fertil Steril; 2013 Sep; 100(3):810-7. PubMed ID: 23725802
[TBL] [Abstract][Full Text] [Related]
18. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
Altadill T; Dowdy TM; Gill K; Reques A; Menon SS; Moiola CP; Lopez-Gil C; Coll E; Matias-Guiu X; Cabrera S; Garcia A; Reventos J; Byers SW; Gil-Moreno A; Cheema AK; Colas E
Sci Rep; 2017 Aug; 7(1):8803. PubMed ID: 28821813
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
